Research Article

Definition of a Novel Cuproptosis-Relevant lncRNA Signature for Uncovering Distinct Survival, Genomic Alterations, and Treatment Implications in Lung Adenocarcinoma

Figure 3

The excellent efficacy of the cuproptosis-relevant lncRNA signature in predicting LUAD prognosis. (a, b) K-M curves of OS between low- and high-risk subsets and ROC curves at 1- and 3-year OS, together with 5-year OS. (C, D) K-M curves of DFS between subsets, and ROC curves at 1- and 3-year DFS, together with 5-year DFS. (e, f) K-M curves of DSS between subsets and ROC curves at 1- and 3-year DSS, together with 5-year DSS. (h, h) K-M curves of PFS between subsets and ROC curves at 1- and 3-year PFS, together with 5-year PFS. (i) K-M curves of OS between two subsets stratified by the median values of expression of prognostic cuproptosis-relevant lncRNAs.
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
(i)